ARROWHEAD PHARMACEUTICALS, INC. — Director's Dealing 2014

Aug 19, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ARROWHEAD RESEARCH CORP (ARWR)
CIK: 0000879407
Period of Report: 2014-08-15

Reporting Person: GIVEN DOUGLAS B (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-08-15	Common Stock	M	5000	$2.01	Acquired	25000	Direct
2014-08-15	Common Stock	S	5000	$13.9001	Disposed	20000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-08-15	Stock Option (right to buy)	$2.01	M	5000	Disposed	2023-05-06	Common Stock (5000)	Direct

Footnotes

F1: Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions.